09:55 AM EST - Bioniche Life Sciences : announced that it had entered into a special agreement with the U.S. Food and Drug Administration (FDA) regarding the Phase III clinical trials of its Mycobacterial Cell Wall-DNA complex used for bladder cancer. The agreement is expected to speed up the approval of the treatment by the FDA, according to the company.
shares T.BNC are trading up 3 cents at $0.91.
